Novo Nordisk (NYSE:NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE:LLY) released promising trial results for its experimental obesity pill, orforglipron, which showed weight loss and ...

Eli Lilly reports positive late-stage data for its weight-loss pill. BMO analyst says Lilly's update will weigh on shares of ...

A weight loss company has moved into a new office suite in Chippenham. CheqUp, which provides weight loss injections and treatments, has taken over the ground floor of Turnpike House, a two-storey ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

Discover how excess weight silently damages your joints through both mechanical stress and inflammation, and learn effective ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Doctors and patients have been hoping for a pill version that would be easier to take, in contrast to an injectable.

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Recent research suggests that behavioral and environmental strategies could extend meal duration and reduce the amount of ...